First-trimester ductus venosus screening for cardiac defects: a meta-analysis

Απλή σελίδα τεκμηρίου
dc.contributor.authorPapatheodorou, S. I.en
dc.contributor.authorEvangelou, E.en
dc.contributor.authorMakrydimas, G.en
dc.contributor.authorIoannidis, J. P. A.en
dc.date.accessioned2015-11-24T18:28:09Z
dc.date.available2015-11-24T18:28:09Z
dc.identifier.issn1470-0328-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/16130
dc.rightsDefault Licence-
dc.subjectchromosomal abnormalitiesen
dc.subjectcongenital heart diseaseen
dc.subjectductus venosusen
dc.subjectnuchal translucencyen
dc.subjectfetal nuchal translucencyen
dc.subjectcongenital heart-defectsen
dc.subjectchromosomally normal fetusesen
dc.subjectblood-flow assessmenten
dc.subject1st trimesteren
dc.subjectdoppler velocimetryen
dc.subjectgestationen
dc.subjectabnormalitiesen
dc.subjectpregnancyen
dc.subjectthicknessen
dc.titleFirst-trimester ductus venosus screening for cardiac defects: a meta-analysisen
heal.abstractBackground Heart defects are the most common congenital abnormalities. Objective We aimed to evaluate in a meta-analysis the screening performance of abnormal ductus venosus (DV) Doppler waveform for detection of congenital heart disease (CHD) in chromosomally normal fetuses. Search strategy Studies were retrieved from a search of MEDLINE, ISI, SCOPUS and EMBASE (from 1999 to March 2011) using the keywords 'ductus venosus', 'DV', 'chromosomal abnormalities', 'congenital heart disease' and 'nuchal translucency'. Selection criteria We considered all studies that examined the diagnostic performance of DV in the first trimester for CHD in chromosomally normal fetuses. We included studies that were limited to fetuses with increased nuchal translucency (NT), normal NT, and studies that examined fetuses regardless of NT status. Data collection and analysis Seven studies (n = 50 354) regardless of the NT status, nine studies (n = 2908) with increased NT and seven studies (n = 47 610) with normal NT were included in the meta-analysis. We drew hierarchical summary receiver operating characteristic (HSROC) curves using the parameters of the fitted models. Main results In populations including participants regardless of NT status, the summary sensitivity and specificity of DV for detecting CHD were 50 and 93%, respectively. In participants with increased NT, the summary sensitivity and specificity were 83 and 80%, and in those with normal NT, they were 19 and 96%, respectively. Authors' conclusions The estimated performance of DV assessment for detection of CHD in chromosomally normal fetuses can be considered in evaluating the potential use and limitations of this screening test.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.primaryDOI 10.1111/j.1471-0528.2011.03029.x-
heal.identifier.secondary<Go to ISI>://000296203900004-
heal.identifier.secondaryhttp://onlinelibrary.wiley.com/store/10.1111/j.1471-0528.2011.03029.x/asset/j.1471-0528.2011.03029.x.pdf?v=1&t=h0xk1tub&s=a17c98be187b58c2f92627ab28e139a7f7cb11c7-
heal.journalNameBjog-an International Journal of Obstetrics and Gynaecologyen
heal.journalTypepeer reviewed-
heal.languageen-
heal.publicationDate2011-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών και Τεχνολογιών. Τμήμα Βιολογικών Εφαρμογών και Τεχνολογιώνel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή:
Κατεβάστε

Συλλογές

Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)